S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.15%) $0.928
USD/NOK
(0.31%) $10.87
USD/GBP
(0.02%) $0.792
USD/RUB
(-0.03%) $92.55

Realtime updates for Athersys Inc [ATHX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

Quarter results today
(tns 2024-03-29)

Expected move: +/- 8.50%

Last Updated8 Jan 2024 @ 15:58

-33.50% $ 0.0135

Live Chart Being Loaded With Signals

Commentary (8 Jan 2024 @ 15:58):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions...

Stats
Today's Volume 6.46M
Average Volume 1.77M
Market Cap 833 204
EPS $-0.150 ( 2023-11-16 )
Next earnings date ( $0 ) 2024-03-29
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.00818
ATR14 $0.00600 (26.55%)
Insider Trading
Date Person Action Amount type
2023-12-18 Hansen Maia Sell 67 Common Stock
2023-10-04 Hansen Maia Sell 23 149 Common Stock
2023-10-04 Camardo Daniel A. Sell 19 993 Common Stock
2023-09-18 Hansen Maia Sell 67 Common Stock
2023-08-17 Mayhugh Neema Buy 27 428 NonQualified Stock Option (right to purchase)
INSIDER POWER
19.66
Last 94 transactions
Buy: 8 476 520 | Sell: 1 272 175

Volume Correlation

Long: -0.02 (neutral)
Short: 0.37 (neutral)
Signal:(49.051) Neutral

Athersys Inc Correlation

10 Most Positive Correlations
ADN0.951
INVZ0.95
ARVL0.946
ATNF0.946
KZR0.944
CAAS0.943
MPAA0.94
BPYPN0.939
PETS0.939
MMAT0.939
10 Most Negative Correlations
NVCN-0.951
STAY-0.929
TIOA-0.926
AVEO-0.924
VCXA-0.921
XM-0.92
PCRX-0.919
BRIVU-0.919
ITMR-0.915
ENER-0.914

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Athersys Inc Correlation - Currency/Commodity

The country flag -0.12
( neutral )
The country flag 0.29
( neutral )
The country flag 0.00
( neutral )
The country flag -0.07
( neutral )
The country flag 0.45
( neutral )
The country flag 0.45
( neutral )

Athersys Inc Financials

Annual 2022
Revenue: $5.33M
Gross Profit: $5.33M (100.00 %)
EPS: $-5.70
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.150
Q2 2023
Revenue: $49 000.00
Gross Profit: $49 000.00 (100.00 %)
EPS: $-0.620
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.450

Financial Reports:

No articles found.

Athersys Inc

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators